Mark Sulkowski, M.D.


Descriptive text is not available for this image

  • Associate Professor of Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore MD
  • Medical Director, Viral Hepatitis Center, Divisions of Infectious Diseases and Gastroenterology/Hepatology at the Johns Hopkins University School of Medicine in Baltimore, MD


  • 4 textbook chapters
  • 14 Non-peer reviewed articles
  • 50 Peer-reviewed scientific articles


  • Fellowship, Infectious Diseases: Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Residency: Duke University Medical Center, Durham, North Carolina
  • Internship: Duke University Medical Center, Durham, North Carolina
  • MD: Temple University School of Medicine, Philadelphia, Pennsylvania


  • American Association for the Study of Liver Diseases
  • European Association for the Study of the Liver
  • Infectious Diseases Society of America


  • Clinical trials and outcomes research related to the management of chronic hepatitis C including novel antiviral agents
  • Outcomes research related to HCV and liver disease in HIV-infected persons
  • Co-investigator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Hepatitis B Clinical Research Network
  • Co-investigator: AIDS Clinical Trials Group (ACTG)


  • Dr. Sulkowski has received institutional research grants (to Johns Hopkins University) and/or served as a scientific consultant/advisor for: Boehringer Ingelheim, Human Genome Sciences, Vertex, Indenix, Merck, Valeant, BMS, Tibotec, Roche, and Schering, and government grants or research funding (R01 DA13806 and R01DA16065)

Mark Sulkowski, M.D. is a sample topic from the Johns Hopkins Author Bios.

To view other topics, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. .

Last updated: January 21, 2014